Melanoma Trials in Bedford Park, Australia
Conditions / Melanoma / Bedford Park, Australia
Melanoma has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT02599402 | Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma | COMPLETED | PHASE3 |
| NCT04032704 | A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT03470922 | A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT04370587 | A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05608291 | A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05858736 | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05727904 | Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. | RECRUITING | PHASE3 |
| NCT06190951 | A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma | ACTIVE_NOT_RECRUITING | PHASE2 |